[Bleeding and surgery in the treatment with new oral anticoagulants. The management can be complicated by the lack of specific antidotes]

MeSH terms

• Administration, Oral
• Anticoagulants / administration & dosage
• Anticoagulants / adverse effects*
• Anticoagulants / antagonists & inhibitors
• Anticoagulants / pharmacokinetics
• Antidotes / therapeutic use
• Benzimidazoles / administration & dosage
• Benzimidazoles / adverse effects
• Benzimidazoles / antagonists & inhibitors
• Benzimidazoles / pharmacokinetics
• Critical Pathways
• Dabigatran
• Drug Monitoring
• Elective Surgical Procedures
• Hemorrhage / chemically induced*
• Hemorrhage / therapy
• Humans
• Morpholines / administration & dosage
• Morpholines / adverse effects
• Morpholines / antagonists & inhibitors
• Morpholines / pharmacokinetics
• Pyrazoles / administration & dosage
• Pyrazoles / adverse effects
• Pyrazoles / antagonists & inhibitors
• Pyrazoles / pharmacokinetics
• Pyridines / administration & dosage
• Pyridines / adverse effects
• Pyridines / antagonists & inhibitors
• Pyridines / pharmacokinetics
• Pyridones / administration & dosage
• Pyridones / adverse effects
• Pyridones / antagonists & inhibitors
• Pyridones / pharmacokinetics
• Risk Factors
• Rivaroxaban
• Thiophenes / administration & dosage
• Thiophenes / adverse effects
• Thiophenes / antagonists & inhibitors
• Thiophenes / pharmacokinetics